Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Obstet Gynecol Neonatal Nurs. 2012 Feb 29;41(2):180–190. doi: 10.1111/j.1552-6909.2011.01330.x

Table 1.

Demographics of Women on MMT and BMT

Variables MMT Group (n = 136) BMT Group (n =16)

n Mean SD N Mean SD P
Maternal Dose (mg) on Admission* 136 131.3 69.9 16 18.6 14.3 -----
Maternal Age in Years 135 25.4 4.0 16 24.4 3.5 0.30
Gravidity with Current Pregnancy 135 3.2 2.4 16 2.8 1.8 0.44
Parity Prior to Delivery 134 2.5 0.99 16 1.8 0.98 0.15
GA When Prenatal Care Started in Weeks 113 13.5 6.9 10 14.2 9.2 0.79
Number of Prenatal Visits Attended 6 7.2 4.1 1 13 0.24
Reported Use of Tobacco: 131 (97%) 15(93.8%) 0.76
 None 22 (16.8%) 3 (20.0%)
 0–1/2 PPD 47 (35.9%) 6 (40.0%)
 1/2 PPD-1 PPD 38 (29.0%) 4 (26.7%)
 >1 PPD 24 (18.3%) 2 (13.3%)
Reported Use of Alcohol 10 (8.3%) 1 (9.1%) 0.89
Use of SSRIs 13 (10.1%) 1 (8.3%) 0.67
Use of Benzodiazepines (prescribed or illicit) 21 (16.2%) 2 (16.7%) 0.76
Use of Marijuana 50 (42.7%) 2 (18.2%) 0.05
Use of Other Opioids 128 (94%) 14 (93%) 0.31

GA = gestational age; PPD = pack per day; SSRIs = selective serotonin reuptake inhibitors. Parametric variables (age, gravida, parity, prenatal visit measures) were analyzed with independent sample t-tests; X2 was used for the remaining variables.

*

dose is not comparable between methadone and buprenorphine so is not statistically compared.